Debrecen, Hungary

Sandor Berenyi

This inventor holds 2 USPTO granted patents. Top assignees: Alkaloida Vegyeszeti Gyar Tiszavasvari, Chinoin Gyogyszer Es Vegyeszeti. Active years: 1979.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Location History:

  • Debrechen, HU (1979)
  • Debrecen, HU (1979)

Company Filing History:


Years Active: 1979

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sandor Berenyi

Introduction

Sandor Berenyi is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new compounds with therapeutic effects. With a total of 2 patents, Berenyi's work showcases his dedication to innovation and improvement in medical treatments.

Latest Patents

Berenyi's latest patents include the development of 7,8-Dihydroisomorphine derivatives, specifically azidoethylmorphine. This new compound exhibits excellent antitussive effects without causing respiratory depression, making it a promising candidate for cough treatment. Another patent focuses on the preparation of pharmaceutically acceptable derivatives of 6-deoxy-6-azido-14-hydroxy-7,8-dihydroisomorphine. This process includes various 3-protected derivatives, which are essential for advancing pharmaceutical applications.

Career Highlights

Throughout his career, Sandor Berenyi has worked with reputable companies such as Chinoin Gyogyszer Es Vegyeszeti and Alkaloida Vegyeszeti Gyar Tiszavasvari. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and development.

Collaborations

Berenyi has collaborated with notable coworkers, including Sandor Makleit and Geza Kiss. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Sandor Berenyi's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medical treatments. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…